A former biotech executive who’s living with terminal cancer wants to reset expectations about new cancer treatments – Markets Insider
Markets Insider |
A former biotech executive who’s living with terminal cancer wants to reset expectations about new cancer treatments
Markets Insider In 2016, for instance, former President Jimmy Carter announced he was cancer-free after using the immunotherapy Keytruda as part of his treatment for melanoma. There’s been a surge of investment in cancer therapies in the past few years as well, with … |
Medgadget (blog) |
Global Cancer Gene Therapy Market is expected to Witness a Steady Growth by 2022
Medgadget (blog) Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient’s cells as a drug to treat disease. Gene therapy holds promise for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia … Gene Therapy Market Trends, Growth, Type and Application, Manufacturers, Regions & forecast to 2022Green Mountain Outlook |
|
Chorkborty-Hoque: London could have new ‘building’ boom
London Free Press “I want London to be the innovation hub of synthetic biology in Ontario and potentially Canada,” says Karas, the conference organizer. After earning a doctorate in bio-technology from Western, he went to San Diego, but returned in 2015. “This city has … |
|
Two Babies Have Been Cancer-Free After Receiving Treatment Created With Gene Editing
Futurism The team combined a novel but promising cell therapy called chimeric antigen receptor T cell (CAR T) with a gene-editing technique called TALENS. The former uses the patient’s immune system to fight cancer, while the latter is a gene editing tool that … |
WhaTech |
‘Nano-in-micro’ stem cell delivery could rescue blood flow after injury
Science Daily Stem cells are promising treatments, but they do not tend to stay at the site or survive long enough to heal the damage. Today, researchers combine micro and nano approaches to improve stem cell therapies and outcomes after ischemia, or inadequate … Report explores the global mesenchymal stem cells marketWhaTech |